AnaptysBio Inc buy UBS Group AG
Start price
17.03.26
/
50%
€58.00
Target price
17.03.27
€78.28
Performance (%)
-23.34%
Price
04.06.26
€44.87
Summary
This prediction is currently active. The prediction for AnaptysBio Inc disappoints with a performance of -23.34%. This prediction currently runs until 17.03.27. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| AnaptysBio Inc | -8.298% | -8.298% |
| iShares Core DAX® | -1,86 % | 0,67 % |
| iShares Nasdaq 100 | -3,32 % | 4,99 % |
| iShares Nikkei 225® | -2,30 % | 6,13 % |
| iShares S&P 500 | -1,31 % | 3,40 % |
Comments by UBS_Group_AG for this prediction
In the thread AnaptysBio Inc diskutieren
AnaptysBio (ANAB) had its price target raised by UBS Group AG from $70.00 to $90.00. They now have a "buy" rating on the stock.
Ratings data for ANAB provided by MarketBeat